Experimental Hematology
Volume 36, Issue 9 , Pages 1098-1109 , September 2008

Rapid and recurrent neutrophil mobilization regulated by T134, a CXCR4 peptide antagonist

Received 28 December 2007 ,Revised 27 March 2008 ,Accepted 31 March 2008.

References 

  1. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565–568
  2. Melchers F, Rolink AG, Schaniel C. The role of chemokines in regulating cell migration during humoral immune responses. Cell. 1999;99:351–354
  3. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032–3043
  4. Broxmeyer HE. Regulation of hematopoiesis by chemokine family members. Int J Hematol. 2001;74:9–17
  5. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2:123–128
  6. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev. 2001;12:313–335
  7. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type 1 membrane proteins. Sciences. 1993;261:600–603
  8. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A. 1994;91:2305–2309
  9. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635–638
  10. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998;393:595–599
  11. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845–848
  12. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O. Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol. 2004;75:604–611
  13. Suratt BT, Petty JM, Young SK, et al. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood. 2004;104:565–571
  14. Patel L, Charlton SJ, Chambers JK, Macphee CH. Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations. Cytokine. 2001;14:27–36
  15. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem. 1998;273:22279–22283
  16. Gonzalo JA, Lloyd CM, Peled A, Delaney T, Coyle AJ, Gutierrez-Ramos JC. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol. 2000;165:499–508
  17. Forster R, Kremmer E, Schubel A, et al. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J Immunol. 1998;160:1522–1531
  18. Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M. Surface expression of CC- and CXC-chemokine receptors on leukocyte subsets in inflammatory joint diseases. Clin Exp Immunol. 2001;126:551–559
  19. Gupta SK, Pillarisetti K, Aiyar N. CXCR4 undergoes complex lineage and inducing agent-dependent dissociation of expression and functional responsiveness to SDF-1 alpha during myeloid differentiation. J Leukoc Biol. 2001;70:431–438
  20. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184:1101–1109
  21. Nagase H, Miyamasu M, Yamaguchi M, et al. Cytokine-mediated regulation of CXCR4 expression in human neutrophils. J Leukoc Biol. 2002;71:711–717
  22. Martin C, Burdon PCE, Bridger G, Gutierrez-Ramos J, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from bone marrow and their return following senescence. Immunity. 2003;19:583–593
  23. Hendrix CW, Flexner C, MacFarland RT, et al. Pharmacokinetics and safety of AMD3100, a novel antagonist of the CXCR4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother. 2000;44:1667–1673
  24. Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102:2728–2730
  25. Devine S, Flomenberg N, Vesole DH, et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol. 2004;22:1095–1102
  26. Lack NA, Green B, Dale DC, et al. Apharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100. Clin Pharmacol Ther. 2005;77:427–436
  27. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of marine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201:1307–1318
  28. Pelus LM, Huimin B, Fukuda S, Wong D, Merzouk A, Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphanuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergize with granulocyte colony-stimulating factor. Exp Hematol. 2005;33:295–307
  29. Arakaki R, Tamamura H, Premanathan M, et al. T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J Virol. 1999;73:1719–1723
  30. Yu L, Cecil J, Peng SB, et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene. 2006;374:174–179
  31. Zhang W, Navenot J, Haribabu B, et al. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C`are weak partial agonists. J Biol Chem. 2002;277:24515–24521
  32. Shen H, Cheng T, Olszak I, et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol. 2001;166:5027–5033
  33. Levesque J-P, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by G-CSF or cyclophosphamide. J Clin Invest. 2003;111:187–196
  34. Christopherson K, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 2003;101:4680–4686
  35. Yang OO, Swanberg SL, Lu Z, et al. Enhanced inhibition of human immunodeficiency virus type 1 by met-stromal-derived factor 1β correlates with down regulation of CXCR4. J Virol. 1999;73:4582–4589
  36. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463–471
  37. Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 2002;17:413–423

PII: S0301-472X(08)00154-9

doi: 10.1016/j.exphem.2008.03.021

Experimental Hematology
Volume 36, Issue 9 , Pages 1098-1109 , September 2008

Article Tools

* Image Usage & Resolution